Prevention of ovarian cancer by administration of progestin products
作者： Gustavo C. Rodriguez
DOI:
关键词:
摘要: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.
lens.org参考文章(182)
Richard G. Barber, Enhanced coupled, even mode terminated baluns, and mixers and modulators constructed therefrom ,(1989)
Thomas K. Kelly, Container for tablets ,(1986)
Andrew Berchuck, Robert C Bast, Cinda M. Boyer, Lorri Everitt, George J. Olt, Andrew P. Soisson, The role of peptide growth factors in epithelial ovarian cancer Obstetrics & Gynecology. ,vol. 75, pp. 255- 262 ,(1990)
Heinrich K. Schnoes, Hector F. DeLuca, Wan F. Lau, Method of inducing the differentiation of malignant cells with secosterol ,(1987)
Joseph Peter Sabatucci, Inhibition of bone loss by 3-(4-acrylamidobenzoyl) benzo b!-thiophenes ,(1997)
MARK J. ARENDS, ANDREW H. WYLLIE, Apoptosis: Mechanisms and Roles in Pathology Experimental pathology. ,vol. 32, pp. 223- 254 ,(1991) , 10.1016/B978-0-12-364932-4.50010-1
Marvin H. Lehr, Reduced melt viscosity CPVC blends containing sulfur and various metal carbonate stabilizers ,(1988)
Richard A. Edgren, Method of contraception using peak progestogen dosage ,(1981)
Gary H. Posner, Todd D. Nelson, Vitamin D3 analogues ,(1993)
Enrico Di Salle, Franco Buzzetti, Paolo Lombardi, Androst-4-ene-3,17-diones and process for their preparation ,(1987)